Kala Bio, Inc. (KALA)
0.595
+0.06
(+10.62%)
USD |
NASDAQ |
Sep 09, 14:40
Kala Bio Market Cap : 11.51M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 10.40M |
| September 04, 2026 | 9.811M |
| September 03, 2026 | 10.85M |
| September 02, 2026 | 10.10M |
| September 01, 2026 | 10.29M |
| August 31, 2026 | 13.01M |
| August 28, 2026 | 13.35M |
| August 27, 2026 | 15.71M |
| August 26, 2026 | 15.78M |
| August 25, 2026 | 15.88M |
| August 24, 2026 | 15.38M |
| August 21, 2026 | 15.86M |
| August 20, 2026 | 16.25M |
| August 19, 2026 | 17.41M |
| August 18, 2026 | 17.38M |
| August 17, 2026 | 17.60M |
| August 14, 2026 | 17.58M |
| August 13, 2026 | 17.18M |
| August 12, 2026 | 16.43M |
| August 11, 2026 | 15.71M |
| August 10, 2026 | 14.04M |
| August 07, 2026 | 13.90M |
| August 06, 2026 | 13.70M |
| August 05, 2026 | 13.03M |
| August 04, 2026 | 13.81M |
| Date | Value |
|---|---|
| August 03, 2026 | 14.56M |
| July 31, 2026 | 14.05M |
| July 30, 2026 | 13.56M |
| July 29, 2026 | 12.52M |
| July 28, 2026 | 12.27M |
| July 27, 2026 | 12.47M |
| July 24, 2026 | 11.79M |
| July 23, 2026 | 11.35M |
| July 22, 2026 | 13.69M |
| July 21, 2026 | 13.63M |
| July 20, 2026 | 13.94M |
| July 17, 2026 | 14.42M |
| July 16, 2026 | 15.75M |
| July 15, 2026 | 19.15M |
| July 14, 2026 | 17.91M |
| July 13, 2026 | 20.26M |
| July 10, 2026 | 21.84M |
| July 09, 2026 | 25.10M |
| July 08, 2026 | 25.84M |
| July 07, 2026 | 28.07M |
| July 06, 2026 | 28.63M |
| July 02, 2026 | 31.23M |
| July 01, 2026 | 33.09M |
| June 30, 2026 | 32.16M |
| June 29, 2026 | 38.85M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.797B |
| Alnylam Pharmaceuticals, Inc. | 34.00B |
| Anika Therapeutics, Inc. | 281.44M |
| Savara, Inc. | 1.110B |
| Vericel Corp. | 1.999B |
Market Cap Related Metrics
| Price to Book Value | 1.272 |
| Price | 0.595 |
| Earnings Yield | -12.42K% |